Skip to content

John Paulson new Valeant director

June 19, 2017
  • Drugmaker’s shares rise as much as 5.3% in NY trading
  • Paulson became largest holder after Ackman left in March

Billionaire hedge fund manager John Paulson joined the board of Valeant Pharmaceuticals International Inc., a move that could help comfort investors who saw longtime backer Bill Ackman bail out earlier this year.

Following Ackman’s exit in March, Paulson’s firm became Valeant’s biggest shareholder — with a stake of 5.7 percent at the end of that month, based on data compiled by Bloomberg. The stock jumped 4.7 percent to $13.26 at 10:04 a.m. in New York Monday.

Paulson is taking the new role after the stock bounced back from recent lows in the past months, as Chief Executive Officer Joseph Papa, who joined last year, raised the company’s outlook and sold a few assets to chip away at the debt. The shares are still down more than 80 percent from their 2015 peak, after Valeant became embroiled in accounting and drug pricing scandals. Ackman, who’d been an active board member and fervent champion even during the rocky times, said the investment was a “huge mistake.”

Paulson shot to fame betting on the collapse of the U.S. housing market in 2007. A decade later, the hedge-fund manager is struggling to persuade investors to stick with him after a string of missteps on everything from gold to drug stocks. The firm’s primary merger arbitrage strategy fell 25 percent last year as drug stocks including Valeant, Allergan Plc and Teva Pharmaceutical Industries Ltd. plunged.

Paulson’s firm has about about $10 billion in assets, just $2 billion of which is outside capital, according to its most recent regulatory filing. Most of the remaining $8 billion is Paulson’s own fortune. Paulson founded it in 1994. At its peak in 2011, the firm oversaw $38 billion.

Sign of Frustration?

Paulson became Valeant director on June 14, bringing the number of members to 11, Valeant said Monday in a statement. Even after Ackman’s departure, Paulson won’t be the only big investor on the board. Robert Hale, a partner with hedge fund ValueAct, has been a director since August 2015. ValueAct boosted its stake to more than 5 percent recently, and remains among the biggest holders after first investing in mid-2006 in what was then a small experimental-drug developer.

David Maris, an analyst at Wells Fargo and a longtime critic of Valeant, viewed the new appointment with skepticism.

“It could be a sign that a major holder is frustrated with the pace and direction of change,” Maris, who rates the shares underperform, said in a note to investors. “We do not know what new domain experience that Paulson brings to Valeant’s board that was not already present, especially with ValueAct already on the board.”

Paulson is joining Valeant while winding down his role as a director at American International Group Inc. Paulson was elected last year to the insurer’s board after proposing that then-Chief Executive Officer Peter Hancock split the company into three separate businesses. Paulson’s fund sold AIG shares while he was on the board, and AIG has since replaced Hancock with Brian Duperreault. AIG said in April that Paulson wouldn’t stand for reelection “due to his other time commitments.”

“With his significant business and financial expertise, John will be a strong addition to the board,” Valeant CEO Papa said in the statement Monday. “His experience will be especially valuable as we continue to execute on our transformational strategy to turnaround Valeant.”

https://bloom.bg/2rvujB9

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: